Log in to search using one of your social media accounts:


Orencia Aids Beta Cell Function (CME/CE)

(MedPage Today) -- Immune modulation with abatacept (Orencia) helped slow the decline of beta cell function in patients with recent-onset type 1 diabetes even after the treatment stopped, researchers reported.
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news

Related Links:

More News: Abatacept | Diabetes | Diabetes Type 1 | Endocrinology | HIV AIDS | Orencia